# TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles

> **NCT02497846** · PHASE4 · COMPLETED · sponsor: **Teoxane SA** · enrollment: 15 (actual)

## Conditions studied

- Crow's Feet Wrinkles

## Interventions

- **DEVICE:** TEOSYAL® PureSense Redensity [I]/MicronJet®

## Key facts

- **NCT ID:** NCT02497846
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02497846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02497846, "TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02497846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*